DHR: Danaher Corporation Company Value to Net Income

Danaher Corporation Inc. - graphic logo of issuer DHR

A steady stream of funds from laboratory consumables guarantees the financial stability of Danaher Corp. (DHR). The company's relative P/E valuation on the GURU.Markets platform confirms this trend, where the indicator value is 37.90. Business growth is based on the sale of expensive equipment followed by regular reagent supplies. The implementation of ESG standards and responsible resource management during production create additional value.

Danaher Corporation (DHR) Price to Earnings Ratio: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns for Danaher Corp (DHR)

- stock quotes and analyst forecast:
- market capitalization information:
Comprehensive company analysis:Danaher Corp - DHR
Manufactured product of Danaher Corporation

Production automation at Danaher Corp. (DHR) correlates directly with the company's historical average P/E, reflecting market expectations regarding business scalability. This metric compares current market capitalization with net income, measuring the cost of one dollar of annual earnings. Daily price action captures the balance of supply and demand, eliminating gaps in the assessment of fundamental value. This allows investors to precisely determine an entry point while accounting for system engineering maintenance costs.

Competing companies

P/E Multiple Intuitive Surgical, Inc.|Price to Earnings Ratio BDX (Becton, Dickinson and Company)|STE (STERIS Corporation) - Company Value to Net Income|P/E Multiple WST (westpharma.com)|Business Payback Period baxter.com (BAX)|Masimo Corp - P/E Multiple|Business Payback Period Stevanato Group SpA STVN|Teleflex Corp (TFX) - Price to Earnings Ratio|Price to Earnings Multiple MMSI|Price to Earnings Ratio envistaco.com|ICU Medical (ICUI) - Business Payback Period|Price to Earnings Ratio XRAY (DENTSPLY SIRONA Inc.)|Market Price to Net Income Ratio LMAT|Price to Earnings Ratio AtriCure Corp ATRC|Company Value to Net Income STAA|NAGE: Price to Earnings Ratio|ZIMV - P/E Multiple|AngioDynamics Inc (ANGO) - Price to Earnings Ratio|Price to Earnings Ratio Cerus|TKNO (teknova.com) - P/E Multiple|Market Cap to Earnings Monogram Orthopedics Inc. MGRM|Price to Earnings Ratio Sharps Tech (STSS)|InfuSystem Inc - Price to Earnings Multiple|Utah Medical Products - Price to Earnings Ratio|Market Price to Net Income Ratio KRMD (KORU Medical Systems)|NYXH - Price to Earnings Ratio|Business Payback Period Microbot Medical, Inc MBOT|Pro-Dex Corp (PDEX) - Price to Earnings Ratio|Market Cap to Net Income ZTEK (Zentek Ltd.)|Price to Earnings Ratio Elutia|Milestone Scientific Inc (MLSS) - Business Payback Period|Price to Earnings Ratio NXGL (NEXGEL, Inc.)|RVP (Retractable Technologies, Inc.) - Company Value to Net Income|Harvard Bioscience, Inc. - Price to Earnings Ratio|P/E Multiple femasys.com FEMY|MHUA: Price to Earnings Ratio|Business Payback Period predictive-oncology.com POAI|Callan JMB Inc (CJMB) - Price to Earnings Ratio|Price to Earnings Multiple ATRI|NURO (NeuroMetrix Inc) - P/E Multiple